Mannarino O - Search Results

1

BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells.

Camero S, Camicia L, Marampon F, Ceccarelli S, Shukla R, Mannarino O, Pizer B, Schiavetti A, Pizzuti A, Tombolini V, Marchese C, Dominici C, Megiorni F. Camero S, et al. Among authors: mannarino o. Cancer Lett. 2020 Jun 1;479:71-88. doi: 10.1016/j.canlet.2020.03.011. Epub 2020 Mar 19. Cancer Lett. 2020. PMID: 32200036

2

Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition.

Megiorni F, McDowell HP, Camero S, Mannarino O, Ceccarelli S, Paiano M, Losty PD, Pizer B, Shukla R, Pizzuti A, Clerico A, Dominici C. Megiorni F, et al. Among authors: mannarino o. J Exp Clin Cancer Res. 2015 Oct 6;34:112. doi: 10.1186/s13046-015-0228-4. J Exp Clin Cancer Res. 2015. PMID: 26445453 Free PMC article.

3

DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.

Megiorni F, Camero S, Ceccarelli S, McDowell HP, Mannarino O, Marampon F, Pizer B, Shukla R, Pizzuti A, Marchese C, Clerico A, Dominici C. Megiorni F, et al. Among authors: mannarino o. Oncotarget. 2016 Nov 29;7(48):79342-79356. doi: 10.18632/oncotarget.12688. Oncotarget. 2016. PMID: 27764816 Free PMC article.

4

PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines.

Camero S, Ceccarelli S, De Felice F, Marampon F, Mannarino O, Camicia L, Vescarelli E, Pontecorvi P, Pizer B, Shukla R, Schiavetti A, Mollace MG, Pizzuti A, Tombolini V, Marchese C, Megiorni F, Dominici C. Camero S, et al. Among authors: mannarino o. J Cancer Res Clin Oncol. 2019 Jan;145(1):137-152. doi: 10.1007/s00432-018-2774-6. Epub 2018 Oct 24. J Cancer Res Clin Oncol. 2019. PMID: 30357520 Free PMC article.

5

c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.

Vitali R, Cesi V, Nicotra MR, McDowell HP, Donfrancesco A, Mannarino O, Natali PG, Raschellà G, Dominici C. Vitali R, et al. Among authors: mannarino o. Int J Cancer. 2003 Aug 20;106(2):147-52. doi: 10.1002/ijc.11187. Int J Cancer. 2003. PMID: 12800187 Free article.

6

Detection and clinical significance of disseminated tumour cells at diagnosis in bone marrow of children with localised rhabdomyosarcoma.

McDowell HP, Donfrancesco A, Milano GM, Clerico A, Mannarino O, Altavista P, Boldrini R, Cozza R, Inserra A, Dominici C. McDowell HP, et al. Among authors: mannarino o. Eur J Cancer. 2005 Oct;41(15):2288-96. doi: 10.1016/j.ejca.2005.07.007. Eur J Cancer. 2005. PMID: 16169716

7

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.

Diomedi-Camassei F, McDowell HP, De Ioris MA, Uccini S, Altavista P, Raschellà G, Vitali R, Mannarino O, De Sio L, Cozzi DA, Donfrancesco A, Inserra A, Callea F, Dominici C. Diomedi-Camassei F, et al. Among authors: mannarino o. Clin Cancer Res. 2008 Jul 1;14(13):4119-27. doi: 10.1158/1078-0432.CCR-07-4446. Clin Cancer Res. 2008. PMID: 18593989

8

Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours.

Uccini S, Colarossi C, Scarpino S, Boldrini R, Natali PG, Nicotra MR, Perla FM, Mannarino O, Altavista P, Boglino C, Cappelli CA, Cozzi D, Donfrancesco A, Kokai G, Losty PD, McDowell HP, Dominici C. Uccini S, et al. Among authors: mannarino o. Br J Cancer. 2006 Jul 3;95(1):49-55. doi: 10.1038/sj.bjc.6603212. Epub 2006 Jun 6. Br J Cancer. 2006. PMID: 16755292 Free PMC article.

9

Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome.

Uccini S, Perotti D, Colarossi C, Stoppacciaro A, Sardella M, Mannarino O, Collini P, Casieri P, Cozzi D, Amoroso L, Spreafico F, Radice P, Dominici C. Uccini S, et al. Among authors: mannarino o. Pediatr Blood Cancer. 2008 Sep;51(3):344-8. doi: 10.1002/pbc.21507. Pediatr Blood Cancer. 2008. PMID: 18293378

10

Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.

Uccini S, Mannarino O, McDowell HP, Pauser U, Vitali R, Natali PG, Altavista P, Andreano T, Coco S, Boldrini R, Bosco S, Clerico A, Cozzi D, Donfrancesco A, Inserra A, Kokai G, Losty PD, Nicotra MR, Raschellà G, Tonini GP, Dominici C. Uccini S, et al. Among authors: mannarino o. Clin Cancer Res. 2005 Jan 1;11(1):380-9. Clin Cancer Res. 2005. PMID: 15671569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page